leadf
logo-loader
viewKymeris Therapeutics

Kymeris Therapeutics co-founder says solid cancers will cause 1/5 deaths in Americans

Kymeris Therapeutics co-founder Gordon Lee sat down with Proactive's Christine Corrado at BIO CEO in New York. The Toronto-based late discovery stage firm has a solid cancer immunotherapy platform, and is seeking funding to complete pre-clinical development, advancing to a stage suitable for a large pharmaceutical strategic partner.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Mandalay Resources latest drilling shows impressive results from Youle...

Mandalay Resources (TSE: MND-OTCQB: MNDJF) President and CEO Dominic Duffy joined Steve Darling from Proactive with news the company has seen some very strong numbers from the latest drill results on the Youle Deposit at their Costerfield Project. Duffy telling Proactive the numbers returned...

2 days ago

2 min read